Novartis Becomes LATEST SUPPORTER

Novartis is an innovative medicines company working to reimagine medicine to improve and extend people’s lives, empowering patients, healthcare professionals, and societies in the face of serious disease. Their medicines reach more than 250 million people worldwide. They focus on areas such as oncology, cardiovascular diseases, immunology, and neuroscience.

Novartis has provided financial sponsorship to Cancer Awareness Trust but is not involved in the development or pilot of Cancer Platform.

Rob Hastings, ad interim Chief Medical Officer, said: “Novartis is proud to support Cancer Awareness Trust’s initiative in developing a pioneering platform that harnesses the power of AI to bring trusted, up-to-date, tailored information to cancer patients. We hope the platform can make a real difference and support patients and carers in understanding their conditions better.”

Mike Zatyka, Global Fundraising Director of Cancer Awareness Trust, said: "Novartis' contribution is helping us pilot Cancer Platform with under-supported communities to help ensure this game-changing cancer navigation tool reaches the people who need it most."